Q4 2020 Holdings
Filed 2021-02-12 | 68 holdings | $300.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $101.4M | 4,878,035 | 33.7% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $71.4M | 2,752,222 | 23.8% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $46.6M | 540,837 | 15.5% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $36.5M | 5,576,471 | 12.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $18.4M | 62,491 | 6.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $17.2M | 1,532,282 | 5.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $6.9M | 1,943,712 | 2.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $320.3K | 6,661,503 | 0.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $184.6K | 4,182,243 | 0.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $163.1K | 2,630,658 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $127.7K | 3,073,147 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $109.6K | 2,768,049 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $101.9K | 2,972,191 | 0.0% |
| Merus N V | COM | N5749R100 | $101.8K | 5,805,571 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $86.2K | 4,273,588 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $77.1K | 1,364,461 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $55.2K | 1,264,754 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $53.8K | 3,499,346 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $52.6K | 10,761,593 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $50.8K | 9,816,658 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $45.8K | 1,106,070 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $45.2K | 3,226,769 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $44.2K | 3,705,289 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $43.5K | 2,243,278 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $40.7K | 1,245,912 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $40.3K | 1,854,162 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $37.5K | 10,963,000 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $36.9K | 17,426,968 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $35.9K | 9,544,262 | 0.0% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $26.2K | 718,788 | 0.0% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $25.5K | 750,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $23.8K | 11,180,994 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $23.8K | 514,370 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $22.3K | 6,929,690 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $21.4K | 4,361,238 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $20.2K | 2,149,057 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $19.5K | 878,524 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $17.7K | 1,038,678 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $13.7K | 5,494,582 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $13.3K | 954,996 | 0.0% |
| Novus Therapeutics Inc | COM | 67011N204 | $11.8K | 763,279 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $11.3K | 1,343,667 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $10.7K | 4,049,162 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $10.6K | 2,695,418 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $10.4K | 4,522,051 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $10.0K | 3,304,963 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $9.7K | 4,012,404 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $9.2K | 800,000 | 0.0% |
| Contrafect Corp(CFRXUSD) | COM NEW | 212326300 | $8.1K | 1,600,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $7.5K | 3,739,704 | 0.0% |